Life Sciences Market Research Report

Report Filter Reset All

Sort By Price

Published Date

Category

Clear All

Publishers

Clear All

Report Type

Continents

Clear All

Regions

Clear All

Countries

Clear All

Pharma & Healthcare

Global (United States, European Union and China) Hepatocellular Carcinoma Drugs Market Research Report 2019-2025

HCC is the most common form of primary liver cancer in adults and occurs mainly in the patients with underlying liver disease and cirrhosis. The disease orig...

$3,280.00 16 August, 2019 | QYResearch

HCC is the most common form of primary liver cancer in adults and occurs mainly in the patients with underlying liver disease and cirrhosis. The di...

Pharma & Healthcare

Global (United States, European Union and China) Keloid Treatment Market Research Report 2019-2025

Keloid is an overgrowth of the scar tissues that develop from a wound. Keloid development usually happens after the wound has healed. Keloids grow beyond the...

$3,280.00 16 August, 2019 | QYResearch

Keloid is an overgrowth of the scar tissues that develop from a wound. Keloid development usually happens after the wound has healed. Keloids grow ...

Pharma & Healthcare

Global (United States, European Union and China) Acute Ischemic Stroke Therapeutics Market Research Report 2019-2025

AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AI...

$3,280.00 16 August, 2019 | QYResearch

AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological fu...

Pharma & Healthcare

Global (United States, European Union and China) Bone Wax Market Research Report 2019-2025

Bone wax is a sterile mixture of beeswax that includes a wax-softening agent, such as isopropyl palmitate, used to stop bleeding from bone surfaces. Bone wax...

$3,280.00 16 August, 2019 | QYResearch

Bone wax is a sterile mixture of beeswax that includes a wax-softening agent, such as isopropyl palmitate, used to stop bleeding from bone surfaces...

Pharma & Healthcare

Global (United States, European Union and China) Central Nervous System Treatment Market Research Report 2019-2025

The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central ner...

$3,280.00 16 August, 2019 | QYResearch

The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for c...

Pharma & Healthcare

Global (United States, European Union and China) Collagen Protein Market Research Report 2019-2025

Collagen is the main structural protein in the extracellular space in the various connective tissues in animal bodies. As the main component of connective ti...

$3,280.00 16 August, 2019 | QYResearch

Collagen is the main structural protein in the extracellular space in the various connective tissues in animal bodies. As the main component of con...

Pharma & Healthcare

Global (United States, European Union and China) Fluticasone propionate Market Research Report 2019-2025

Fluticasone propionate belongs to a class of drugs known as corticosteroids, specifically glucocorticoids, which are hormones that predominantly affect the m...

$3,280.00 16 August, 2019 | QYResearch

Fluticasone propionate belongs to a class of drugs known as corticosteroids, specifically glucocorticoids, which are hormones that predominantly af...

Pharma & Healthcare

Global (United States, European Union and China) Iclusig Market Research Report 2019-2025

Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acut...

$3,280.00 16 August, 2019 | QYResearch

Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive ...

Pharma & Healthcare

Global (United States, European Union and China) Rivastigmine Oral Market Research Report 2019-2025

Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkin...

$3,280.00 16 August, 2019 | QYResearch

Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease ...

Pharma & Healthcare

Global (United States, European Union and China) Sartans Market Research Report 2019-2025

Sartans are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure)...

$3,280.00 16 August, 2019 | QYResearch

Sartans are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood...